Target Population

For patients who need hematopoietic stem cell transplant

Description

Stem cell transplantation is an effective treatment for leukemia and other hematological diseases, aimed at rebuilding a healthy hematopoietic system. Our team conducts all tests related to stem cell transplantation, including DSA detection, cell procurement, and transfusion management. These tests are performed by experienced professionals who prioritize patient safety and ensure the quality of the stem cell products used. At the same time, we work to enhance the success rate and efficiency of the procedures.

Our team received accreditation from AABB, the most authoritative organization of blood medicine and cell therapy, in both 2021 and 2023, demonstrating our contributions to the field of cell therapy have been internationally recognized. We place great emphasis on report accuracy, helping clinicians make precise diagnoses and treatment decisions. Our contributions are reflected in improved patient satisfaction and higher success rates. We demonstrate our expertise in stem cell testing by conducting research, collaborating with clinical departments, and participating in international conferences.

Key Highlights

Detecting Donor-Specific Antibodies (DSA) and using desensitization to accelerate neutrophil (ANC) and platelet (PLT) engraftment, and to improve success rates in mismatched allogeneic transplantation.
Providing post-thawing tests for stem cell products to help clinicians accurately understand the condition of thawed products.
Providng HLA matched PLT to ensure transfusion efficiency and reduce waste of medical resources.